Why Modestly Dosed Supplements Still Sell — and When That's Fine
Formulas like MemoHoney are dosed below research levels for practical reasons: a once-daily capsule holds under a gram of actives, low doses keep side effects and interactions minimal, and convenience drives adherence. That trade-off is reasonable when the label is honest and the pricing reflects it; it becomes a problem only when modest doses are marketed as clinical strength.
- Capsule ceiling ≈ 700–800 mg
- Low dose = low side-effect risk
- Convenience drives adherence
- Honest labelling is the test
The physics of a capsule
A size-00 capsule holds roughly 700–900 mg of powder depending on density. Subtract flow agents and you have perhaps 700 mg for actives. A research-dose nitric oxide formula needs 3,000 mg or more of citrulline alone. There is no way to fit it. Manufacturers who want a once-daily capsule therefore choose between a low dose of the right ingredients or a full dose of nothing useful — and MemoHoney chose the former.
The safety and interaction argument
Gram-level arginine and citrulline meaningfully lower blood pressure in some people, interact with nitrates and PDE5 inhibitors, and can cause GI upset. A formula sold online without a prescriber in the loop has a legitimate reason to stay well below those thresholds. Modest dosing is partly a liability decision — and from the consumer's side, it means the product is very unlikely to hurt anyone who ignores the warnings. That is not nothing.
Adherence beats potency you won't take
The supplement with the best research is the one you actually take daily. Powders that need mixing, multi-capsule servings and mid-day doses all lose users within weeks. A single morning capsule has the highest adherence of any format. For a benefit that accumulates over weeks, the modest-dose-high-adherence product can outperform the strong-dose-abandoned one in practice.
Where the trade-off stops being fair
It stops being fair when the marketing implies research-level results, when the price is set as if the doses were clinical, or when a blend hides how small the amounts are. MemoHoney passes the first two tests on this site — we state the doses are modest, and at $49 per bottle the daily cost is about $1.63 — and it passes the third by disclosing everything. Whether $1.63 a day is worth a gentle, unproven effect is a personal call, and the 60-day refund is how you make it.
What this means for MemoHoney
MemoHoney is a modest-dose, high-convenience, fully disclosed product. Judged as that, it is reasonable. Judged as a clinical-strength nitric oxide formula, it is not — and we never present it as one.
| Ingredient | Per capsule | Research / RDA range |
|---|---|---|
| Niacin (Vitamin B3) | 7.5 mg NE | 14–16 mg NE (RDA) |
| Calcium | 18 mg | 1,000–1,200 mg (RDA) |
| L-Arginine (base) | 200 mg | 3,000–6,000 mg |
| L-Arginine AKG 2:1 | 200 mg | 3,000–6,000 mg |
| L-Citrulline HCl | 100 mg | 3,000–8,000 mg |
| L-Citrulline Malate | 100 mg | 3,000–8,000 mg |
| Beta-Alanine | 40 mg | 2,000–6,000 mg |
Every MemoHoney amount is printed on the label — no proprietary blend. Full analysis on the ingredients page; mechanism on how it works.
Key takeaways
- Capsule capacity, not intent, caps the doses.
- Low doses buy a wide safety margin.
- Honesty in labelling and pricing is what makes modest dosing acceptable.
FAQ
For raw dose, yes. For daily adherence and safety margin, the capsule wins. They serve different buyers.
Not if the label discloses the amounts and the claims match them. It is a scam when modest amounts are hidden or oversold.
Compare cost per day against what you would pay for the same active content as a bulk powder, then decide what the convenience is worth to you.